Gene · 1438
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic characterization and prognostic significance of copy number alterations in Tunisian patients with acute lymphoblastic leukemia. | PLoS One | 2026 | 41632752 | PubTator, text mining | PubMed |
| Knowledge gaps and research priorities to understand sex differences in immunity. | PLoS Biol | 2026 | 41628075 | PubTator, text mining | PubMed |
| Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma. | Clin Transl Med | 2026 | 41612852 | PubTator, text mining | PubMed |
| SMARTCLOTH Prototype for Dietary Management in Patients With Diabetes Mellitus: Tutorial on Human-Centered Design Methodology for Health Care Hardware Development. | J Med Internet Res | 2026 | 41564321 | PubTator, text mining | PubMed |
| Recent perspectives on macrophage memory: types, mechanisms, and characteristics in pulmonary diseases. | Cell Commun Signal | 2026 | 41540448 | PubTator, text mining | PubMed |
| Reply. | J Vasc Surg Venous Lymphat Disord | 2026 | 41519514 | PubTator, text mining | PubMed |
| A critical guideline for controlling monocyte-derived macrophages phenotypes. | Front Immunol | 2025 | 41809998 | PubTator, text mining | PubMed |
| Case Report: Blood single-cell analysis of a IVB high-grade serous ovarian cancer patient presenting a favorable prognosis. | Front Oncol | 2025 | 41367869 | PubTator, text mining | PubMed |
| A Hereditary Pulmonary Alveolar Proteinosis Caused by a Novel Hemizygous Variation of the CSF2RA Gene Case Report and Literature Review. | Mol Genet Genomic Med | 2025 | 41311221 | PubTator, text mining | PubMed |
| Adverse prognosis of GM-CSF expression in human cutaneous melanoma. | Neoplasia | 2025 | 41108827 | PubTator, text mining | PubMed |
| Mature CD209+CD83+CCR7+ dendritic cells infiltrate the arterial wall in giant cell arteritis and derive from in-situ monocyte differentiation. | Sci Rep | 2025 | 41107388 | PubTator, text mining | PubMed |
| Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancer. | Nat Commun | 2025 | 40998804 | PubTator, text mining | PubMed |
| Effect of quorum quenching on toluene biodegradation in fungal-bacterial biotrickling filters: Insights from long-term performance and microbial mechanism. | J Environ Manage | 2025 | 40992306 | PubTator, text mining | PubMed |
| Enhancing diagnostic reliability in non-invasive health Monitoring: An analytical framework for optimizing magnetic sensor-skin interactions in biomedical applications. | Mater Today Bio | 2025 | 40969392 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| CSF2RA promotes gastric cancer progression through activation of the JAK2/STAT3 signaling pathway. | J Mol Histol | 2025 | 40913748 | PubTator, text mining | PubMed |
| High-Resolution aCGH Analysis of the Jurkat Cell Line: Copy Number Alterations and Their Association With Cancer Hallmarks. | Cancer Genomics Proteomics | 2025 | 40883026 | PubTator, text mining | PubMed |
| Immunoevasion strategies for African swine fever virus: Modulation of antigen presentation pathways. | Virulence | 2025 | 40817451 | PubTator, text mining | PubMed |
| Fbxo42 promotes the degradation of Ataxin-2 granules to trigger terminal Xbp1 signaling. | Nat Commun | 2025 | 40804044 | PubTator, text mining | PubMed |
Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system. | Immunother Adv | 2025 | 40735486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1438/papers?page=2